Discussion
A gene therapy that delivers instructions to produce a longer-lasting version of the clotting protein missing or deficient in hemophilia B may improve treatment effectiveness while maintaining a favorable safety profile, a study in mice suggests. Researchers in Belgium, working in a lab, combined the genetic instructions for a…